Prospective observational study of Baricitinib in patients treated with corticosteroids for SARS-CoV-2 pneumonia
Latest Information Update: 19 Oct 2020
Price :
$35 *
At a glance
- Drugs Baricitinib (Primary) ; Anakinra; Hydroxychloroquine; Immune globulin; Interferon beta-1b; Lopinavir/ritonavir; Methylprednisolone; Tofacitinib
- Indications COVID-19 pneumonia
- Focus Therapeutic Use
- 19 Oct 2020 New trial record
- 06 Oct 2020 Results published in the Rheumatology